Ximenia Caffra (Ximenia caffra): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Ximenia caffra work for wound healing?

Ximenia caffra promotes wound healing through its combination of active compounds. Tannins provide astringent effects that help contract wound edges and reduce bleeding, while flavonoids offer antioxidant protection against tissue damage. Ximeninic acid and oleic acid in the seed oil support skin barrier repair and reduce local inflammation. These compounds work synergistically to accelerate tissue regeneration. Evidence level: C, based on preclinical studies demonstrating anti-inflammatory and antimicrobial properties.

Does Ximenia caffra interact with any medications?

No well-documented drug interactions exist for Ximenia caffra in current scientific literature. However, the tannin content in bark extracts may theoretically reduce absorption of certain medications, particularly alkaloids and some minerals, when taken simultaneously. Patients on anticoagulant or antiplatelet medications should exercise caution, as some plant compounds may affect bleeding parameters. Always consult a healthcare provider before combining herbal remedies with prescription drugs. Evidence level: C.

What is the recommended dosage for Ximenia caffra bark?

Traditional use suggests one cup of bark decoction daily for inflammatory conditions. To prepare, simmer approximately 5-10 grams of dried bark in 250ml of water for 15-20 minutes, then strain. For topical use, Ximenia seed oil can be applied directly to affected skin areas two to three times daily. Standardized commercial extracts are not widely available, so dosing relies on traditional preparation methods. Evidence level: Traditional. Consult a qualified herbalist for personalized dosing guidance.

Is Ximenia caffra safe to use during pregnancy?

Ximenia caffra bark and root preparations are contraindicated during pregnancy. Traditional evidence suggests these parts may stimulate uterine contractions, potentially causing miscarriage or premature labor. Pregnant women should avoid all internal use of bark or root extracts. The ripe fruit pulp is consumed as food in Southern Africa and is generally considered safe nutritionally when eaten in normal dietary amounts. Evidence level: C. Always consult a healthcare provider before using any herbs during pregnancy.

What are the traditional uses of Ximenia caffra?

Ximenia caffra has extensive traditional use in Southern African medicine. The bark and roots are prepared as decoctions for inflammatory conditions, wound healing, and various skin complaints. The seed oil is applied topically for dermatological conditions and skin moisturizing. The fruit is consumed fresh or dried as a nutritious food source, providing vitamin C and essential minerals. Traditional healers also use preparations for oral infections and digestive complaints. Evidence level: Traditional to C.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 25 PubMed articles · model: gemma4:31b

Summary

Ximenia caffra, commonly known as 'sour plum', is a wild indigenous African tree used traditionally for food and the treatment of various human and veterinary ailments [PMID:26944235, PMID:40012125].

Background

Ximenia caffra Sond. (Ximeniaceae) is an indigenous tree found in sub-Saharan and Southern Africa [PMID:26944235, PMID:40012125].

Traditional uses

It is used topically and orally to treat wounds, sexually transmitted infections (STIs), infertility, stomach ache, fever, eye problems, diarrhoea, bilharzia, malaria, intestinal worms, impotence, and coughs [PMID:26944235, PMID:40012125]. Seed oil is used as a moisturiser, soap, and shampoo for damaged hair [PMID:26944235]. In ethnoveterinary medicine, the bark and fruits are used to treat dermatophilosis, foot rot, saddle sores, and to control ectoparasites [PMID:26944235, PMID:23054800].

Active compounds

The plant contains polyphenols and flavonoids [PMID:40012125]. Leaf extracts contain gallic acid, catechin, quercetin, kaempferol, and quercetin-rutinoside [PMID:25785232]. Fruit skin extracts show high levels of total phenolics and flavonoids [PMID:30071585].

Mechanism of action

Leaf extracts inhibit the mRNA expression of proinflammatory genes including IL-6, iNOS, and TNF-α [PMID:25785232]. Polyphenolic compounds contribute to antioxidant, anti-inflammatory, anticancer, and antimicrobial activities [PMID:40012125].

Clinical evidence

Evidence DArthritis (Rat Model)

Aqueous ethanolic seed extract showed in vitro anti-inflammatory activity (IC50 = 26.01 ± 0.85 µg/ml) and in vivo anti-arthritic activity in antigen-induced arthritis rats [PMID:41495193]

Evidence DBreast Cancer (In Vitro)

Seed oils exhibit anti-proliferative effects on hormone-dependent (MCF-7) and cytotoxic effects on hormone-independent (MDA-MB-231) breast cancer cells [PMID:35129016]

Evidence DBacterial Infections (In Vitro)

Root extracts demonstrate antibacterial activity against various strains, including those from Staphylococcus, Enterococcus, Pseudomonas, Escherichia, Klebsiella, and Salmonella genera [PMID:9533435, PMID:20161933]

Evidence DFungal Infections (In Vitro)

Root extracts show fungistatic and fungicidal activity against Candida spp. [PMID:8786762]

Evidence DHelicobacter pylori (In Vitro)

Root extracts contain compounds with antimicrobial activity against H. pylori [PMID:8874968]

Evidence D

Safety & adverse effects

In rat models, substituting soya bean meal with Ximenia caffra kernel meal was evaluated for effects on blood and liver metabolic substrates and general clinical biochemistry [PMID:26344703, PMID:30417991]. No specific adverse effects in humans are detailed in the provided abstracts.

Evidence summary

The evidence is primarily based on in vitro studies, animal models, and ethnobotanical reviews (Level C and D). There are no human clinical trials (RCTs) or meta-analyses provided.

PubMed sources

1.PMID: 26944235 (2016) — Ximenia caffra Sond. (Ximeniaceae) in sub-Saharan Africa: A synthesis and review of its medicinal potential. · Journal of ethnopharmacology
2.PMID: 40012125 (2025) — Ximenia caffra Sond. the magic wild indigenous plant that offers immense contribution as food and medicine. · Natural product research
3.PMID: 35129016 (2022) — Differential Expression of Platelet Activation Markers, CD62P and CD63, after Exposure to Breast Cancer Cells Treated with Kigelia Africana, Ximenia Caffra and Mimusops Zeyheri Seed Oils In Vitro. · Nutrition and cancer
4.PMID: 41495193 (2026) — In vitro anti-inflammatory potential and in vivo anti-arthritis activities of Ximenia caffra extract on antigen-induced arthritis in rats. · Scientific reports
5.PMID: 26344703 (2016) — Effect of dietary Ximenia caffra kernel meal on blood and liver metabolic substrate content and the general clinical biochemistry of Sprague Dawley rats.

Ximenia Caffra

Sources & Citations

Calculate a safe dose of Ximenia Caffra